AZTEC: Open-label, prospective, single-arm, titrate-to-goal study evaluating the safety and efficacy of olmesartan medoxomil/amlodipine in patients with mild to moderate (Stage 1) and challenging (Stage 2) hypertension

Trial Profile

AZTEC: Open-label, prospective, single-arm, titrate-to-goal study evaluating the safety and efficacy of olmesartan medoxomil/amlodipine in patients with mild to moderate (Stage 1) and challenging (Stage 2) hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Sep 2010

At a glance

  • Drugs Olmesartan medoxomil/amlodipine (Primary)
  • Indications Hypertension
  • Focus Registrational; Therapeutic Use
  • Acronyms AZTEC
  • Sponsors Daewoong Pharmaceutical; Daiichi Sankyo Inc
  • Most Recent Events

    • 25 May 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top